SMFM

In the study, investigators analyzed the Jada System in 800 patients from October 2020 to April 2022 across 16 hospitals in the United States. Results of the study were presented at the SMFM 43rd Annual Pregnancy Meeting in San Francisco, California.

A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.

An oral concurrent session at SMFM’s 42nd Annual Pregnancy Meeting highlighted an analysis of pregnancy outcomes after optimal prenatal opioid use disorder care.

An oral presentation at the Society for Maternal-Fetal Medicine’s (SMFM) 42nd Annual Pregnancy Meeting explored possible associations with marijuana use and nausea and vomiting in early pregnancy.

An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.

In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.

Researchers presented a study at the SMFM 42nd Annual Pregnancy Meeting to assess if early gestational diabetes (GDM) screening is associated with improved perinatal outcomes.

At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.

Researchers presented their oral abstract on the association between lactation and the gut microbiome during the SMFM 42nd Annual Pregnancy Meeting.

At the 2022 virtual SMFM conference, a poster session highlighted a study on prenatal ultrasound findings in pregnant women with SARS-CoV-2 infection.

Registration is now open for the Society for Maternal-Fetal Medicine's (SMFM) 42nd Annual Pregnancy Meeting, to be held from January 31 to February 5, 2022, at the Gaylord Palms Resort and Convention Center near Orlando, Florida.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

For treating inflammatory pain in endometriosis, inflammatory factors that promote angiogenesis and neuroangiogenesis are encouraging targets, according to a systematic review in the journal Biomedicines.

A prospective study from the People’s Republic of China has concluded that menopausal symptoms in women with premature ovarian insufficiency (POI) were significantly higher than in women with natural menopause.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

“We are very concerned about increases in SMM noted in recent years in the United States,” said principal investigator Dena Goffman, MD.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which will be held from Jan. 25 to Jan. 30.

Florida’s Pregnancy Related Mortality Ratio (PRMR) shows a significant decrease in pregnancy-related mortality rates among Hispanic and non-Hispanic Black women, according to a study presented at SMFM’s 2021 Virtual Annual Meeting.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which will be held from Jan. 25 to Jan. 30.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held from Jan. 25 to Jan. 30.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which will be held from Jan. 25 to Jan. 30.

“Whatever you do for me but without me, you do against me.” That was the theme of a scientific forum on Wednesday titled, “Practicing equitable global health,” as part of SMFM’s 2021 Virtual Annual Meeting.

Blood pressure (BP) measurements are higher when taken at alternative locations like the wrist and forearm, according to a prospective study of pregnant patients.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held Jan. 25 to Jan. 30.

Loïc Sentilhes, MD, PHD, presented data on tranexamic acid (TXA) for the prevention of postpartum hemorrhage after cesarean delivery: the TRAAP2 trial, on Wednesday at SMFM's 2021 Virtual Annual Meeting.

Rates of pregnancy complications due to opioid use disorder quadrupled from 1999 to 2014, according to data from Townsel’s presentation, which resulted in four times as many infants born with neonatal abstinence syndrome (NAS) in 2014 than in 1999.